Last updated on June 2016

A Safety and Tolerability Study of an Investigational Drug ALN-TTRSC02 in Healthy Subjects

Brief description of study

The purpose of this study is to determine the safety, tolerability, pharmacokinetics and pharmacodynamics of ALN-TTRSC02 in healthy subjects.

Clinical Study Identifier: NCT02797847

Contact Investigators or Research Sites near you

Start Over

Alnylam Clinical Trials Hotline Call ...

Clinical Trial Site
London, United Kingdom
  Connect »